Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial

被引：0
|
作者：
Emanuele Bosi
Carlo Bosi
Patrizia Rovere Querini
Nicasio Mancini
Giliola Calori
Annalisa Ruggeri
Cecilia Canzonieri
Luciano Callegaro
Massimo Clementi
Francesco De Cobelli
Massimo Filippi
Marco Bregni
机构：
[1] IRCCS Ospedale San Raffaele,Unit of Internal Medicine
[2] Vita-Salute San Raffaele University,Unit of Virology
[3] University of Milan Medical School,Clinical Trial Center
[4] IRCCS Ospedale San Raffaele,Unit of Radiology
[5] IRCCS Ospedale San Raffaele,Unit of Neurology
[6] IRCCS Ospedale San Raffaele,undefined
[7] IRCCS Ospedale San Raffaele,undefined
来源：
Trials | / 21卷
关键词：
IFNβ-1a; COVID-19; SARS-CoV-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial
    Bosi, Emanuele
    Bosi, Carlo
    Querini, Patrizia Rovere
    Mancini, Nicasio
    Calori, Giliola
    Ruggeri, Annalisa
    Canzonieri, Cecilia
    Callegaro, Luciano
    Clementi, Massimo
    De Cobelli, Francesco
    Filippi, Massimo
    Bregni, Marco
    [J]. TRIALS, 2020, 21 (01)
  • [2] A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
    Davoudi-Monfared, Effat
    Rahmani, Hamid
    Khalili, Hossein
    Hajiabdolbaghi, Mahboubeh
    Salehi, Mohamadreza
    Abbasian, Ladan
    Kazemzadeh, Hossein
    Yekaninejad, Mir Saeed
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [3] Study of the effects of interferon β-1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study
    Fallahzadeh, Mohammad
    Pourhoseingholi, Mohamad A.
    Boroujeni, Masoud G.
    Besharati, Sajad
    Mardani, Masoud
    Shabani, Minoosh
    Shokouhi, Shervin
    Amirdosara, Mahdi
    Hajiesmaeili, Mohammadreza
    Gachkar, Latif
    Roshan, Baran
    Zangi, Masoud
    Mirmomeni, Golshan
    Irvani, Seyed S. N.
    Darazam, Ilad Alavi
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1488 - 1493
  • [4] Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
    Seyed Sina Naghibi Irvani
    Maryam Golmohammadi
    Mohamad Amin Pourhoseingholi
    Shervin Shokouhi
    Ilad Alavi Darazam
    [J]. Trials, 21
  • [5] Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
    Irvani, Seyed Sina Naghibi
    Golmohammadi, Maryam
    Pourhoseingholi, Mohamad Amin
    Shokouhi, Shervin
    Darazam, Ilad Alavi
    [J]. TRIALS, 2020, 21 (01)
  • [6] Interferon β-1a in primary progressive MS -: An exploratory, randomized, controlled trial
    Leary, SM
    Miller, DH
    Stevenson, VL
    Brex, PA
    Chard, DT
    Thompson, AJ
    [J]. NEUROLOGY, 2003, 60 (01) : 44 - 51
  • [7] Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia
    Bosi, Carlo
    Ferrarese, Roberto
    De Lorenzo, Rebecca
    Mancini, Nicasio
    Bosi, Emanuele
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 110 : 104 - 106
  • [8] An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
    Ader, Florence
    Peiffer-Smadja, Nathan
    Poissy, Julien
    Bouscambert-Duchamp, Maude
    Belhadi, Drifa
    Diallo, Alpha
    Delmas, Christelle
    Saillard, Juliette
    Dechanet, Aline
    Mercier, Noemie
    Dupont, Axelle
    Alfaiate, Toni
    Lescure, Francois-Xavier
    Raffi, Francois
    Goehringer, Francois
    Kimmoun, Antoine
    Jaureguiberry, Stephane
    Reignier, Jean
    Nseir, Saad
    Danion, Francois
    Clere-Jehl, Raphael
    Bouiller, Evin
    Navellou, Jean-Christophe
    Tolsma, Violaine
    Cabie, Andre
    Dubost, Clement
    Courjon, Johan
    Leroy, Sylvie
    Mootien, Joy
    Gaci, Rostane
    Mourvillier, Bruno
    Faure, Emmanuel
    Pourcher, Valerie
    Gallien, Sebastien
    Launay, Odile
    Lacombe, Karine
    Lanoix, Jean-Philippe
    Makinson, Alain
    Martin-Blondel, Guillaume
    Bouadma, Lila
    Botelho-Nevers, Elisabeth
    Gagneux-Brunon, Amandine
    Epaulard, Olivier
    Piroth, Lionel
    Wallet, Florent
    Richard, Jean-Christophe
    Reuter, Jean
    Staub, Therese
    Lina, Bruno
    Noret, Marion
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1826 - 1837
  • [9] Interferon beta 1a versus interferon beta 1a plus ribavirin for the treatment of chronic hepatitis c in Chinese patients: A randomized, placebo-controlled trial
    Han, Qunying
    Liu, Zhengwen
    Kang, Wen
    Li, Han
    Zhang, Lei
    Zhang, Ni
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (08) : 2238 - 2245
  • [10] Interferon Beta 1a versus Interferon Beta 1a plus Ribavirin for the Treatment of Chronic Hepatitis C in Chinese Patients: A Randomized, Placebo-Controlled Trial
    Qunying Han
    Zhengwen Liu
    Wen Kang
    Han Li
    Lei Zhang
    Ni Zhang
    [J]. Digestive Diseases and Sciences, 2008, 53 : 2238 - 2245
12345